NCT01184885 2025-05-04
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
Thomas Jefferson University
University of Chicago
University of Rochester
University of Nebraska
Rutgers, The State University of New Jersey
The University of Texas Health Science Center at San Antonio